Working Together to Foster Candidate Success on the edTPA

This action research study examined the effectiveness of one model for supporting candidates in their work in preparing and submitting their edTPA portfolios. Surveys of student teachers and their cooperating teachers were administered and analyzed to determine how the model impacted their experiences with the edTPA. This data can inform implementation efforts at other campuses

Restoring Lateral Incisors and Orthodontic Treatment: Perceptions among General Dentists and Othodontists

The purpose of this study was to identify and compare preferences and perceptions of orthodontists and general dentists when restoring peg-shaped lateral incisors. The investigation sought to summarize these preferences with regard to treatment planning, tooth preparation and interdisciplinary communication. A pair of mailed and electronic surveys was distributed to 1,500 general dentists and orthodontists, respectively. The results indicated that general dentists perceived that general dentists held the primary decision-making responsibility, while orthodontists disagreed (P\u3c0.0001). Orthodontists prioritized the treatment goals of Class I canine relationship and overbite/overjet more significantly than general dentists, whom valued tooth proportions more highly (P\u3c0.0001). General dentists reported receiving significantly less input than orthodontists report seeking (P\u3c0.0001).The consensus of both groups showed that the tooth should be positioned centered mesiodistally and guided by the gingival margins incisogingivally. Both groups agree that orthodontists must improve communication to improve treatment results

Novel Polypyridyl Ruthenium(II) Complexes Containing Oxalamidines as Ligands.

The complexes [Ru(bpy)2(H2TPOA)](PF6)2 ⋅ 4H2O, (1); [Ru(Me-bpy)2(H2TPOA)](PF6)2 ⋅ 2H2O, (2); [Ru(bpy)2(H2TTOA)](PF6)2 ⋅ 2H2O, (3); [Ru(Me-bpy)2(H2TTOA)](PF6)2 ⋅ 2H2O, (4) and {[Ru(bpy)2]2(TPOA)}(PF6)2 ⋅ 2H2O, (5) (where bpy is 2,2´bipyridine; Me-bpy is 4,4´- dimethyl-2,2´-bipyridine; H2TPOA is N, N´, N´´, N´´´- tetraphenyloxalamidine; H2TTOA is N, N´, N´´, N´´´- tetratolyloxalamidine) have been synthesized and characterized by 1H-NMR, FAB-MS, infrared spectroscopy and elemental analysis. The X-ray investigation shows the coordination of the still protonated oxalamidine moiety via the 1,2−diimine unit. The dimeric compound (5) could be separated in its diastereoisomers (5´) and (5´´) by repeated recrystallisation. The diastereomeric forms exhibit different 1H-NMR spectra and slightly shifted electronic spectra. Compared with the model compound [Ru(bpy)3]2+, the absorption maxima of (1)–(5) are shifted to lower energies. The mononuclear complexes show Ru(III/II)- couples at about 0.9 V vs SCE, while for the dinuclear complex two well defined metal based redox couples are observed at 0.45 and 0.65 V indicating substantial interaction between the two metal centres

Technology and dementia: the future is now

Background: Technology has multiple potential applications to dementia from diagnosis and assessment to care delivery and supporting ageing in place. Objectives: To summarise key areas of technology development in dementia and identify future directions and implications. Method: Members of the US Alzheimer’s Association Technology Professional Interest Area involved in delivering the annual pre-conference summarised existing knowledge on current and future technology developments in dementia. Results: The main domains of technology development are as follows: (i) diagnosis, assessment and monitoring, (ii) maintenance of functioning, (iii) leisure and activity, (iv) caregiving and management. Conclusions: The pace of technology development requires urgent policy, funding and practice change, away from a narrow medical approach, to a holistic model that facilitates future risk reduction and pre- vention strategies, enables earlier detection and supports implementation at scale for a meaningful and fulfilling life with dementia